0001441844-12-000002.txt : 20121116 0001441844-12-000002.hdr.sgml : 20121116 20121116135443 ACCESSION NUMBER: 0001441844-12-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121115 FILED AS OF DATE: 20121116 DATE AS OF CHANGE: 20121116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baker Mark Robert CENTRAL INDEX KEY: 0001331438 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 121211104 MAIL ADDRESS: STREET 1: 120 STATE STREET CITY: BROOKLYN STATE: NY ZIP: 11201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2012-11-15 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001331438 Baker Mark Robert 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 1 0 0 CEO Common Stock 2012-11-15 4 P 0 48833 1.686 A 93672 D This transaction was executed in multiple trades at prices ranging from $1.620 to $1.710. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Mark R. Baker 2012-11-16